Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA guidance on cell/tissue donor screening test:

This article was originally published in Clinica

Executive Summary

The FDA has issued a guidance on how manufacturers, which currently sell test kits to screen for the presence of disease in a cadaveric blood specimen, can expand the indication so the test can be used to screen for disease in donors of human cells, tissues and cellular and tissue-based products. Such a screening test is now necessary in the wake of a recent final rule requiring that donors of cells and tissue be tested for the presence of certain communicable diseases. Currently, only one company - Genetic Systems, a subsidiary of Sanofi Diagnostics Pasteur - markets a test kit for cadaveric blood specimens.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060219

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel